Evidence map›Paper›PMID 40578346›Full record

ArticleMolecular cell2025

The DNA replication checkpoint prevents PCNA/RFC depletion to protect forks from HLTF-induced collapse in human cells.

Agostina P Bertolin, Berta Canal, Mona Yekezare, Anne Early, Jingkun Zeng, Rachael Instrell, Michael Howell, John F X Diffley

Abstract read
In one paragraph

Article in Molecular cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Ubiquitin and SUMO pathways in DNA replication and replication-coupled repair.Critical reviews in biochemistry and molecular biology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Agostina P BertolinChromosome Replication Laboratory, The Francis Crick Institute, London NW1 1AT, UK.
Berta CanalChromosome Replication Laboratory, The Francis Crick Institute, London NW1 1AT, UK.
Mona YekezareChromosome Replication Laboratory, The Francis Crick Institute, London NW1 1AT, UK.
Anne EarlyChromosome Replication Laboratory, The Francis Crick Institute, London NW1 1AT, UK.
Jingkun ZengChromosome Replication Laboratory, The Francis Crick Institute, London NW1 1AT, UK.
Rachael InstrellHigh Throughput Screening Laboratory, The Francis Crick Institute, London NW1 1AT, UK.
Michael HowellHigh Throughput Screening Laboratory, The Francis Crick Institute, London NW1 1AT, UK.
John F X DiffleyChromosome Replication Laboratory, The Francis Crick Institute, London NW1 1AT, UK. Electronic address: john.diffley@crick.ac.uk.

Funding

Wellcome Trust FC001066
6 · The paper itself

Abstract

The DNA replication checkpoint is crucial for maintaining genome stability after genotoxic stress; without it, stalled DNA replication forks cannot restart normally, excess DNA replication origins are activated, DNA damage and single-stranded DNA (ssDNA) accumulate, S phase does not finish, and cells die. Preventing excess origin firing suppresses all these effects. Here, we show in human cells that when replication is not restrained by a functional checkpoint, excess DNA synthesis sequesters the processivity factor PCNA and its loader, replication factor C (RFC), preventing normal fork restart. Nascent DNA ends unprotected by RFC/PCNA are attacked by the helicase-like transcription factor (HLTF), causing irreversible replication fork collapse and hyperaccumulation of ssDNA. This explains how the checkpoint stabilizes stalled replication forks and has implications for how origin firing is normally coordinated with fork progression. Loss of HLTF suppresses fork collapse and cell lethality in checkpoint-deficient cells, which has implications for how resistance to anti-checkpoint therapies may arise.

Indexed as

DNA-Binding ProteinsDNA ReplicationProliferating Cell Nuclear AntigenReplication Protein CTranscription FactorsDNA DamageDNA, Single-StrandedHeLa CellsHumansS PhaseDNA-Binding ProteinsDNA, Single-StrandedHLTF protein, humanPCNA protein, humanProliferating Cell Nuclear AntigenReplication Protein CTranscription FactorsDNA damageDNA replication checkpointDNA replication fork collapseDNA replication fork stabilizationHLTFOkazaki fragmentsPCNApolymerase αRFCRPA exhaustion

Identifiers

PMID40578346
PMCPMC7619400

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.